Browse by Medical Category
Allergy & Clinical Immunology Unit
Allergy Associates at Massachusetts General Hospital is committed to providing our patients with accurate information and assistance regarding the Epi-Pen recall.
The Epi-Pen recall was initiated after an initial, previous recall of Epi-Pens in Europe and Australia related to two incidents were identified as a device delivery malfunction, seemingly isolated to a small mechanical piece in the body of the device. No similar issues have arisen in U.S. distributed devices and there was no patient injury as a result.
A voluntary recall of 10 percent of the devices in the U.S. from lots distributed between December 2015 and July 2016 was initiated according to an Epi-Pen representative for the purpose of testing to identify if a similar problem exists.
The procedure for the patient is to:
Information sheets will be available in Allergy Associates offices with additional information
Stericycle Phone: 877-650-3494
U.S. Impacted Lots:
EpiPen Jr 2-Pak® Auto-Injectors, 0.15 mg
EpiPen 2-Pak® Auto-Injectors, 0.3 mg
EpiPen 2-pak® Auto-Injectors, 0.3 mg
Press Release for Inquiries
Back to Top